Surgical management of otitis media with effusion

This clinical guideline (number 60, Table I) addresses surgical management of this condition in children aged less than 12 years old based on the best available evidence in 2008. The guideline recommends that clinical diagnosis involves clinical history taking, examination, audiometry and tympanometry. Surgical intervention (ventilation tubes) is recommended for those children with persistent bilateral otitis media with effusion (OME) documented over a period of 3 months, with a hearing level in the better ear of 25–30 dB HL or worse, averaged over 0.5, 1, 2 and 4 kHz (core criteria). Surgical intervention is also recommended for children not meeting those audiological criteria in whom OME has a significant impact upon developmental, social or educational status. Adjuvant adenoidectomy is not recommended in the absence of persistent and/or frequent upper respiratory tract symptoms.

Treatments not recommended include antibiotics, topical or systemic antihistamines, decongestants or steroids, and such alternative measures as homeopathy, cranial osteopathy or acupuncture.

An earlier publication by the Scottish Intercollegiate Guidelines Network (2003), which related to the diagnosis and management of childhood OME in primary care, concurred with the non-recommendations produced by NICE but did suggest that autoinflation may be of benefit in some patients.¹⁰

A recent retrospective case note review analysed practice in five UK centres before and after the introduction of the NICE guidelines.Reference Daniel, Kamani, El-Shunnar, Jaberoo, Harrison and Yalamanchili¹¹ This showed that 87 per cent of children with OME had ventilation tubes inserted in accordance with the NICE guidelines. It also showed that a significant number had surgery based on the non-core criteria, suggesting that there is a persisting trend for clinicians to personalise treatment to the individual child.

Cancer service guidance (head and neck)

This guidance (2004) aims to improve outcomes for patients with head and neck cancers. It recommends which healthcare professionals should be involved and where treatment is best delivered. It specifies that cancer networks should identify the units tasked with this objective and that multidisciplinary teams should have patient responsibility. Rapid diagnosis and support services, including long-term community care, are also stressed. The guidance calls for data collection and research input. The document is a systematic review, of remarkable quality, of the evidence base for head and neck cancer management, from surveillance through to post-discharge review and support.

Endoscopic stapling of pharyngeal pouch

The Institute recommends normal arrangements concerning this procedure. The interventional procedure guideline (number 22, November 2003) notes that this technique allows a more rapid recovery and a shorter stay in hospital (1–2 days) than open surgery. However, the procedure should be performed in specialist centres by specifically trained otorhinolaryngologists. Although deemed safe, evidence is based on small case series and therefore more research is welcomed.

A recently published meta-analysis of 585 patients from 15 retrospective case series reported over the last 15 years has confirmed the safety of this procedure.Reference Leong, Wilkie and Webb¹² It showed good outcomes, with 92 per cent of patients resuming oral intake by the second post-operative day, and more than 90 per cent of patients reporting symptom resolution or significant improvement. An overall perforation rate of 4.8 per cent was reported.

It has been suggested that pharyngeal pouch procedures should only be undertaken by otolaryngologists with a primary head and neck interest. This recommendation was based on a single-centre retrospective review of practice.Reference Yeo and Mackenzie¹³

Endoscopic transsphenoidal pituitary adenoma resection

The Institute supports the use of this procedure. The interventional procedure guideline (number 32, December 2003) reports efficacy comparable to conventional surgery. It notes shorter operating times, shorter hospital stay and lower risks of serious complications compared with microscopic resection.

A systematic review, covering 11 studies from 1989 to 2009, showed no difference in major outcome measures (tumour resection extent or change in hormone levels) compared with traditional techniques.Reference Rotenberg, Tam, Ryu and Duggal¹⁴ However, complications, time in operating theatre and in hospital, and patient discomfort were all significantly improved with the endoscopic approach. A recent single-unit, retrospective analysis of 171 cases reported an 85 per cent total tumour resection rate with this technique.Reference Kumar, Darr, Hobbs and Carlin¹⁵

A 10-year follow-up study involving a retrospective case series of 301 patients showed that the total complication rate, which was heavily weighted towards endocrine problems, was relatively high at 26.9 per cent.Reference Frank, Pasquini, Farneti, Mazzatenta, Sciarretta and Grasso¹⁶ There were no comparisons with data from conventional techniques. Surprisingly, there is little high-level evidence comparing traditional microsurgery with endoscopic surgery, with the majority of available data coming from single-institution case series.

Radiofrequency volumetric tissue reduction for turbinate hypertrophy

In this interventional procedure guideline (number 36, January 2004), NICE concluded that there was inadequate evidence to support the use of this procedure routinely, and that usage requires special measures for consent, audit and clinical governance.

A prospective, randomised, controlled trial (RCT) of 30 patients, which compared this technique with microdebrider submucosal resection in 2008, showed no difference in efficacy between the two techniques.Reference Kizilkaya, Ceylan, Emir, Yavanoglu, Unlu and Samim¹⁷

A systematic review of current knowledge on effectiveness and complications (published in 2009) revealed that most of the published studies on nasal radiofrequency ablation were observational, with relatively short follow up.Reference Hytönen, Bäck, Malmivaara and Roine¹⁸ This further emphasises the need for double-blind, placebo-controlled randomised trials.

Level 1 evidence supporting radiofrequency volumetric tissue reduction has been published (in February 2013) in the form of a prospective, randomised, single-blinded crossover trial (n = 22).Reference Bran, Hünnebeck, Herr, Hörmann and Stuck¹⁹ This study presented statistically significant data, showing an advantage for radiofrequency volumetric tissue reduction compared with placebo. The primary outcome measures were based on patient and clinician subjective assessments, as well as rhinomanometry; long-term outcomes were not reported. However, the results of a study that did examine longer-term outcomes seemed to corroborate these findings.Reference Cukurova, Demirhan, Cetinkaya and Yigitbasi²⁰ Neither study reported any intra-operative or post-operative complications.

Further research in this area is warranted.

Cyanoacrylate instillation for occlusion of parotid sinuses

This interventional procedure guideline (number 42, February 2004) states that parotid-skin sinuses, which complicate 10–15 per cent of parotid gland resections, can be managed by injection of lipiodol and cyanoacrylate adhesive. This procedure often follows a period of bandaging and watchful waiting, and is an alternative to radiotherapy and excision of the deep lobe of the gland. In theory, this procedure can be repeated on recurrence. The evidence for both efficacy and safety is inadequate, with only one case report to document its feasibility, and there has been no addition to the literature.

Auditory brainstem implants

The Institute concluded (in interventional procedure guideline number 108, January 2005) that this procedure is suitable for the small proportion of patients who have complete deafness in both ears caused by damage to the vestibulocochlear nerve, as a result of tumour or surgery, and in whom there is no alternative treatment. The data are limited to case series reports on a small number of patients and no long-term data are available. Based on current evidence on safety and efficacy, it is recommended that the procedure is only undertaken by experienced surgical teams.

Since the publication of this guideline, a study of 61 patients who received such devices showed encouraging, long-term results (up to 8 years).Reference Otto, Brackmann, Hitselberger, Shannon and Kuchta²¹ A 10-year follow-up study also observed a high efficacy rate for auditory brainstem implants.Reference Colletti, Shannon, Carner, Veronese and Colletti²² It should be noted that a recent case of bacterial meningitis secondary to stapes footplate malformation was reported in a child with an auditory brainstem implant.Reference Mandalà and Colletti²³

Recent review articles suggest that results are poor compared with cochlear implants, and that auditory brainstem implants are possibly overused in patients who could still benefit from a cochlear implant.Reference Sanna, Di Lella, Guida and Merkus^24, Reference Merkus, Lella, Trapani, Pasanisi, Beltrame and Zanetti²⁵ It was recommended that auditory brainstem implants are used only in severe cochlear hypoplasia or aplasia cases.

Endoscopic dacryocystorhinostomy

The Institute concluded (in interventional procedure guideline number 113, February 2005) that this procedure is now established practice. Efficacy rates are comparable to conventional treatment and there is good evidence to support faster healing rates following endoscopic dacryocystorhinostomy. Complication rates are low, with adverse events found to occur at similar rates with or without the use of lasers. The Institute found little evidence to support the use of silicone tubes to maintain patency.

A subsequent prospective, randomised study of 173 patients supports this guideline; its findings suggested that silicone tube stenting does not increase success rates.Reference Al-Qahtani²⁶ It reported success rates of 96 per cent with silicone stenting, and 91 per cent without (over a one-year follow-up period); these results were not statistically significant. The overall success rate of 94 per cent is better than previous findings.

Clinical tools such as the Lacrimal Symptom Questionnaire can be beneficial in evaluating surgical outcomes.Reference Mistry, Rockley, Reynolds and Hopkins²⁷

Radiofrequency ablation of the soft palate for snoring

According to this interventional procedure guideline (number 124, May 2005), reduction of the volume of palatal tissue by means of radiofrequency ablation is an attractive procedure for patients and clinicians alike, and it can potentially be done as an out-patient procedure under local anaesthesia. Although the evidence base is limited to two small randomised studies, subjective assessment seems to support its efficacy. Objective sleep assessment, however, yielded no significant difference between the ablation and the control groups. Further evidence is limited to case series, with similar results of high patient satisfaction, but low evidence of efficacy on objective assessment.

Comparative studies looking at radiofrequency ablation and laser-assisted uvulopalatoplasty and uvulopalatopharyngoplasty have found pain duration to be significantly shorter following radiofrequency ablation. Bleeding risk was around 2 per cent in a case series of 60 patients.Reference Johnson, Pollack and Wagner²⁸ There are no documented complications of speech or swallowing difficulties. Specialist advisors had no major concerns about the safety of radiofrequency ablation, but noted potential risks of haemorrhage, secondary infections and palatal ulceration. For these reasons, this procedure should not be carried out without special arrangements in place, and specific consideration should be given to patient selection.

More recently, a systematic review of 30 articles, including two RCTs, concluded that radiofrequency ablation is superior to placebo in snoring treatment efficacy.Reference Bäck, Hytönen, Roine and Malmivaara²⁹ Reduced post-operative pain was also reported compared with conventional procedures. Once again, the limitations of subjective assessment and lack of long-term outcomes preclude useful conclusions from this review. Prospective studies looking at longer-term outcomes showed between 25 per centReference Stuck³⁰ and 37 per centReference Hultcrantz, Harder, Loord, Käll, Ydreborg and Wallberg³¹ success rates long-term (follow up was 20 months and 3 years respectively). Although radiofrequency ablation is relatively safe and easy to carry out, patients must be informed regarding the uncertainty of long-term outcomes.

Collagen injection for vocal fold augmentation

The Institute reports (in interventional procedure guideline number 130, June 2005) that this procedure is effective in patients requiring short-term benefit, but evidence on long-term efficacy is lacking.

Subsequent research has suggested that age may influence outcome.Reference Choi, Son, So, Byun, Lee and Yun³² Fifty-nine patients with unilateral vocal fold paralysis underwent vocal fold augmentation with collagen injections. Three months later, these patients were divided into an improved phonation group (n = 44) and unimproved phonation group (n = 15). The improved group was significantly younger than the unimproved group. This same study revealed that the size of the posterior glottic gap had a significant effect on outcome.

Injection laryngoplasty as a stopgap measure in recoverable vocal fold paralysis has also been favourably reported.Reference Arviso, Johns, Mathison and Klein³³ The need for medialisation laryngoplasty has been shown to be lower in patients initially treated with injection laryngoplasty.Reference Prendes, Yung, Likhterov, Schneider, Al-Jurf and Courey³⁴

A US multicentre retrospective review, conducted in 2010, found injection augmentation to be a safe and effective treatment with a high rate of success, whether performed in the awake or asleep patient.Reference Sulica, Rosen, Postma, Simpson, Amin and Courey³⁵

Division of ankyloglossia for breastfeeding

As indicated in this interventional procedure guideline (number 149, December 2005), NICE felt that the division of ankyloglossia (tongue-tie) raised no major safety concerns and could improve breastfeeding. It should however only be performed by properly trained, registered healthcare professionals. Adverse effects are rare, but include bleeding, infection, damage to the submandibular ducts and recurrence.

Reviews on ankyloglossia division indicate that this is a safe and efficacious procedure, corroborating the findings of NICE.Reference Glynn, Colreavy, Rowley and Gendy³⁶ Most recently, a retrospective study of 91 patients found a high level of maternal satisfaction.Reference Steehler, Steehler and Harley³⁷ Eighty per cent of mothers questioned strongly believed that frenotomy benefited their child's ability to breast feed. Maternal satisfaction rates increased to 86 per cent in cases where the procedure was performed in the first week of life.Reference Steehler, Steehler and Harley³⁷

Electrosurgery for tonsillectomy

In addition to the NICE-commissioned systematic review, data were also analysed from the Wales Single-Use Instrument Surveillance Programme (3690 patients) and the National Prospective Tonsillectomy Audit (33 921 patients). As reported in this interventional procedure guideline (number 150, December 2005), NICE concluded there was adequate evidence for the safety and efficacy of electrosurgery, with avoidance of excessive diathermy, during tonsillectomy. The guideline notes that the use of coblation can result in higher rates of haemorrhage than those seen in other techniques. Surgeons should be trained in both cold-steel and ligature, and electrosurgical techniques. In addition, it is helpful if diathermy equipment can record the total energy usage during each operation to allow for future research.

A subsequent study has compared pain scores in children undergoing coblation and electrocautery.Reference Parker and Walner³⁸ Duration of severe pain was shorter and overall pain scores were better in the coblation group. However, when compared with the traditional ‘cold’ technique, coblation had no pain score benefit.Reference Moesgaard and Mirz³⁹

Haemorrhage rates in coblation tonsillectomy were addressed in a meta-analysis published in 2011.Reference Mösges, Hellmich, Allekotte, Albrecht and Böhm⁴⁰ Twenty-four prospective, randomised and controlled studies were included, revealing an overall haemorrhage rate of 4.1 per cent; this rate was comparable to similar techniques.

Tonsillectomy using ultrasonic scalpel

Ultrasonic energy is used to vibrate a disposable blade, allowing the simultaneous dissection and sealing of blood vessels. This is done using lower temperatures than thermal methods.

Three randomised studies were analysed for this interventional procedure guideline (number 178, June 2006). One study's comparative data suggested that post-operative pain duration was shortened with the use of this technique versus diathermy (120 patients). Another suggested that cold-steel dissection lessened this time further. Four other studies looked at the time taken to return to a normal diet. All four found that the ultrasonic scalpel shortened this time compared with both cold-steel and diathermy techniques.

The retrospective studies referred to in the guideline, with total sample sizes of 400 patients, reported primary bleed rates of 1 per cent for ultrasonic scalpel use and 3 per cent for diathermy. It is worth pointing out, however, that these numbers are not in keeping with the larger studies mentioned in the interventional procedure guideline number 150. In these retrospective studies, additional techniques (such as bipolar diathermy or ligatures) were utilised concomitantly with an ultrasonic scalpel to achieve haemostasis.

Secondary haemorrhage data are less robust, with small sample sizes and no statistically significant results between ultrasonic and diathermy groups. These studies agreed with the findings of the National Prospective Tonsillectomy Audit, in that the cold-steel technique with ligatures yielded the lowest secondary re-bleed rates.⁴¹

Tonsillectomy using laser

Several types of laser are used for tonsillectomy, including carbon dioxide, potassium titanyl phosphate (‘KTP’) and contact diode lasers. This interventional procedure guideline (number 186, July 2006) looks at laser vaporisation tonsillectomy, but does not consider laser-assisted tonsillectomy.

Five studies examined post-operative pain and showed that laser tonsillectomy was associated with a higher pain rating than traditional cold-steel methods. Three of those studies also looked at healing and again found worse results for laser treatment. Overall, laser therapy had a higher bleeding rate. However, the types of laser, the power settings and the techniques used were heterogeneous; it is therefore difficult to generalise from the findings of these studies.

A subsequent randomised, controlled comparison of radiofrequency tonsillectomy with laser tonsillectomy revealed little difference in post-operative pain between the two patient groups.Reference Stelter, de la Chaux, Patscheider and Olzowy⁴²

Catheterless oesophageal pH monitoring

The procedure involves placing a capsule under endoscopic guidance, which is secured onto the oesophageal wall by means of a vacuum. This interventional procedure guideline (number 187, July 2006) was based on a ‘rapid review’ of the literature and is not deemed to be a definitive assessment of the procedure. Small studies in the literature review failed to come to a consensus regarding the efficacy of the procedure, although it did seem to be better tolerated than conventional monitoring. There was too little evidence to produce robust guidance.

Therapeutic sialendoscopy

Treatment for obstruction of the salivary glands can include medical therapy, extracorporeal or endoscopic lithotripsy, and sialadenectomy or sialendoscopy. For this interventional procedure guideline (number 218, May 2007), NICE looked at five case series and found that treatment was successful in 82–87 per cent of cases. As with all interventional procedure guidelines, NICE did not compare this therapy with other treatments. The procedure was generally safe, but the case reports did highlight complications, such as ductal wall perforation and lingual nerve damage. This procedure continues to evolve.

Since the publication of this guideline, a sizeable single-centre study of 1154 patients was carried out in Germany.Reference Zenk, Koch, Klintworth, Konig, Konz and Gillespie⁴³ The authors treated over 1000 submandibular and parotid calculi, a significant number of which were removed by sialendoscopy alone. The findings revealed long-term success rates of 90 per cent. Meta-analysis data also support the use of sialendoscopy with regard to efficacy rates, safety and gland-preserving factors.Reference Strychowsky, Sommer, Gupta, Cohen and Nahlieli⁴⁴

Advances in sialendoscopy have meant that this technique can now be used in paediatric populations, with good evidence for its safety and outcome.Reference Jabbour, Tibesar, Lander and Sidman⁴⁵

Soft palate implants for simple snoring

In this interventional procedure guideline (number 240, March 2007), NICE concluded that although there are no major safety concerns regarding this procedure, there is a lack of evidence on efficacy, with small case series data only and a lack of well-controlled comparative data. All studies reviewed showed snoring to improve over short periods of follow up, with no serious adverse events reported. The Institute called for further research, particularly on quality of life outcomes and patient selection data.

A subsequent cohort study of 26 patients compared snoring outcomes before and after soft palate implants (at 52 weeks and 4 years post-implant).Reference Rotenberg and Luu⁴⁶ This showed significant improvements in snoring scale scores at 52 weeks compared with pre-operative scores. However, there was deterioration in snoring scale scores between 52 weeks and 4 years, suggesting that the efficacy of implants may deteriorate over time. The study size was small, and only 23 of the 26 patients were followed up for the full 4 years.

Soft palate implants for obstructive sleep apnoea

No safety concerns are reported in this interventional procedure guideline (number 241, March 2007). However, the evidence for efficacy is lacking. As there are other treatments for this potentially serious condition, the current recommendation is to not use this procedure in the treatment of obstructive sleep apnoea (OSA).

A recent meta-analysis (of seven studies) supports the use of soft Pillar implants for mild to moderate OSA, but notes that high-level evidence is still lacking.Reference Choi, Kim and Cho⁴⁷

Intra-operative nerve monitoring during thyroid surgery

Nerve damage during thyroid surgery is a major concern as it can lead to breathing and vocalisation difficulties. This interventional procedure guideline (number 255, March 2008) concerns nerve monitoring carried out via electrodes attached to the endotracheal tube.

A large, non-randomised trial of almost 30 000 patients compared the rates of nerve damage associated with: not identifying the recurrent laryngeal nerve, identifying it visually or using intra-operative nerve monitoring. The results showed no significant difference between these groups. Smaller studies appeared to show a trend towards a benefit from intra-operative nerve monitoring, but this was not statistically significant. Specialist advisors commented that intra-operative nerve monitoring is of value in proving nerve integrity should litigation arise post-operatively.

A US multi-institutional survey reported that 80 per cent of ENT surgeons who carry out thyroid surgery use intra-operative nerve monitoring technology, with 40 per cent of surgeons choosing to use it in every case.Reference Ho, Carr and Goldenberg⁴⁸

The most recent evidence comes from a single-centre study in Greece, which looked at revision thyroidectomy (n = 91).Reference Prokopakis, Kaprana, Velegrakis, Panagiotaki, Chatzakis and Iro⁴⁹ This showed no significant difference in rates of recurrent laryngeal nerve injury for intra-operative nerve monitoring use compared with non-use. Furthermore, the study found a statistically significant increase in intra-operative time associated with its use.

The most robust evidence is probably that from the International Neural Monitoring Study Group, who reported a review of the literature and their own experience of intra-operative nerve monitoring over 15 years.Reference Randolph, Dralle, Abdullah, Barczynski and Bellantone⁵⁰ The consensus document recommended standards for equipment set-up and endotracheal tube placement, and for dealing with loss of signal. In addition, the authors derived an algorithm for intra-operative problem solving.

Interstitial photodynamic therapy for malignant parotid tumour

This procedure is used for parotid tumour that is recurrent or locally persistent, despite surgery and adjunctive chemotherapy and/or radiotherapy. For this interventional procedure guideline (number 259, April 2008), NICE looked at a total of two case reports and concluded that the procedure should only be used with special arrangements because of the lack of evidence.

Balloon catheter dilatation of paranasal sinus ostia for chronic sinusitis

This interventional procedure guideline (number 273, March 2008) is based on published evidence from one non-randomised controlled trial and three large case series. The Institute concluded that the short-term efficacy of this procedure is adequate, with no major safety concerns. The procedure should be carried out only by surgeons with experience of complex sinus surgery and specific training in the technique. Publications of long-term outcomes are welcomed.

Subsequent retrospective case note reviews of 27 consecutive patients were conducted, in which subjective improvement and sinonasal outcome test (‘SNOT-22’) scores were measured. The results revealed that dilatation was successful in 98 per cent of sinuses in which this procedure was attempted, but subjective improvement was only reported for 62 per cent of patients.Reference Hopkins, Noon, Bray and Roberts⁵¹ It was concluded that this technique, although valuable, has limited applications; the cost of the procedure also needs to be considered.

Following this, a systematic review of the technique called for more RCTs to determine its efficacy over conventional treatment modalities.Reference Ahmed, Pal, Hopkins and Jayaraj⁵²

Low-level evidence was provided in the form of a retrospective, controlled study of 85 patients who were followed up using a questionnaire.Reference Koskinen, Penttilä, Myller, Hammarén-Malmi, Silvola and Haahtela⁵³ The findings suggested that those with chronic rhinosinusitis related comorbidity, or occupational exposure, had a better outcome with traditional endoscopic sinus surgery than with balloon sinuplasty. The study also described a statistically higher rate of antibiotic usage and maxillary sinus puncture after balloon sinuplasty.

Suction diathermy adenoidectomy

In this interventional procedure guideline (number 328, December 2009), NICE concluded that the current evidence on the safety and efficacy of suction diathermy adenoidectomy is adequate to support the use of this procedure under normal arrangements. However, the procedure should be carried out by surgeons with specific training in the use of diathermy for adenoidectomy, because possible thermal damage to surrounding tissues can rarely cause Grisel's syndrome (subluxation of the atlanto-axial joint).

The NICE guidance is based on over 6000 patients' results from five papers, including one meta-analysis for which the level of evidence was concluded to be robust. The studies showed that the efficacy of suction diathermy was similar to that of the traditional ‘cold’ curettage technique in relieving symptoms, but the former procedure was superior in terms of adenoidal tissue removal, bleeding complications and length of hospital stay.

A subsequent postal questionnaire sent to consultant members of ENT UK in 2010 showed that suction diathermy ablation was the preferred routine adenoidectomy technique for only 8.1 per cent of these individuals.Reference Dhanasekar, Liapi and Turner⁵⁴

In 2011, a prospective cohort study was conducted (as part of the National Prospective Tonsillectomy Audit) that compared suction adenoidectomy and traditional curette in patients undergoing adenotonsillectomy.Reference Lowe, Brown and Yung⁵⁵ The findings indicated that the use of suction diathermy had a similar safety profile to the conventional technique.

The use of suction diathermy has also been described as a treatment for chronic nasopharyngitisReference Bartley and Barber⁵⁶ and as a teaching tool.Reference Cartwright, Thorne and Okpala⁵⁷

Balloon dilatation of eustachian tube

This interventional procedure guideline (number 409, November 2011) states that current research evidence is inadequate (in both quality and quantity) to assess the procedure's safety and efficacy. Hence, this procedure should only be used in the context of research.

Preliminary studies have since been carried out, with variable results. One study reported improved symptoms in 71 per cent of 70 adults studied, with one complication reported.Reference Catalano, Jonnalagadda and Yu⁵⁸ However, there have been documented cases of adverse catheter placement, which would appear to limit the use of balloon dilatation. In addition, in a cadaver study, attempts to pass the same tube in the reverse direction, from the tympanum towards the nasopharynx, highlighted the risk of carotid canal damage.Reference Kepchar, Acevedo, Schroeder and Littlefield⁵⁹

Incisionless otoplasty

The technique, which is used to correct protruding ears, is adopted to avoid the complications associated with standard incision, such as anterior skin necrosis or keloid scar formation. This interventional procedure guideline (number 422, March 2012) describes a total of 24 patients from two retrospective case series. Both cases series were published over 12 years ago, and neither study had an adequate period of follow up. The Institute concluded that the technique seems to show good cosmetic results, but more recent and robust research is required.

Endoscopic balloon dilatation for subglottic or tracheal stenosis

In this interventional procedure guideline (number 425, April 2012), NICE concluded that the current evidence on safety and efficacy is inadequate in terms of quality and quantity. The published evidence was found to be related to a variety of different techniques, some of which are no longer used. A few patients experienced some symptomatic relief following this procedure (often after a number of dilatations). However, more data are required.

Micropressure therapy for Ménière's disease

Ménière's disease is thought to be caused by raised endolymph pressure in the inner ear. Micropressure therapy may stimulate endolymph flow via low pressure air pulses through the tympanic membrane.

This interventional procedure guideline (number 426, April 2012) looks at two RCTs that showed a significant improvement in functional level and a reduction in the number of vertigo attacks in the group treated with micropressure versus the group who received a sham treatment. However, there was no long-term follow up beyond two years. Furthermore, it is difficult to interpret these results, as Ménière's disease naturally relapses and remits. The NICE panel concluded that the evidence for efficacy was limited and suggested further research, particularly into long-term outcomes and the need for subsequent surgical treatment.

A subsequent preliminary study showed a statistically significant reduction in vertiginous symptom frequency (compared with pre-treatment) with the use of either the tympanic membrane massage device or the Meniett^® device.Reference Watanabe, Shojaku, Junicho, Asai, Fujisaka and Takakura⁶⁰ Follow up was for 12 months. Patient groups were limited to a maximum of 15 patients.

Continuous positive airway pressure for sleep apnoea

For this technology appraisal (number 139; issued March 2008, reviewed November 2010), NICE looked at 48 RCTs on the effectiveness of continuous positive airway pressure (CPAP) for OSA. A meta-analysis of these studies showed a statistically significant reduction in daytime sleepiness when CPAP was used by those with moderate to severe OSA, and an improvement in blood pressure for patients with severe OSA. It also showed that road safety improved with the use of CPAP. Adherence to treatment was in the range of 65–85 per cent, dropping with time. The treatment is recommended for use in moderate to severe OSA (as determined by the Apnoea–Hypopnoea Index), and in mild OSA cases where symptoms have had a detrimental effect on quality of life and lifestyle measures have failed. The NICE costing team calculated a cost of between £4000 and £9000 per quality-adjusted life year gained, depending on apnoea severity.

Cetuximab for head and neck squamous cell cancer

In this technology appraisal (number 145; issued June 2008, reviewed March 2011), cetuximab, in combination with radiotherapy, is currently recommended for patients with locally advanced head and neck cancer, in whom platinum-based chemotherapy is contraindicated. The patient must also have a good performance status score.

The NICE panel took into account information provided by Merck Pharmaceuticals, the manufacturers of cetuximab. The manufacturers supplied RCT evidence in which cetuximab plus radiotherapy was compared with radiotherapy alone, with 200 patients in each arm. This trial (the Bonner Trial) commenced at a time when chemotherapy was not standard treatment for locally advanced squamous cell cancer. The trial showed longer median survival times and prolonged control of the disease for patients in the cetuximab group. However, NICE noted that patient performance status varied widely prior to treatment, and many of those in the trial were actually suitable for conventional chemotherapy.

The Institute did not initially approve cetuximab, as it did not prove cost effective in this trial. However, on appeal, it was approved for those with a good performance status score (i.e. Karnofsky scores over 90 per cent). The Institute then invited Merck Pharmaceuticals to perform a literature review. However, there was no evidence at the time for cetuximab versus chemoradiotherapy. A recent meta-analysis of four trials comparing cetuximab plus radiotherapy with platinum-based chemoradiotherapy showed no difference in endpoints between the two treatments.Reference Levy, Johnston, Sambrook, Donato, Penrod and Corral⁶¹ Interim results of the Radiotherapy (intensity-modulated radiation therapy), Erbitux^® And CHemotherapy for unresectable carcinomas of head and neck (‘REACH’) trial, which examined the safety and efficacy of cetuximab plus chemoradiotherapy, are now available but the full findings have not yet been published.Reference Jensen, Krauss, Potthoff, Simon, Nikoghosyan and Lossner⁶²

Cochlear implants for severe to profound deafness

For this technology appraisal (number 166; issued January 2009, reviewed February 2011), the committee looked at the devices currently available on the market. The appraisal recommends that unilateral implants are used in children and adults who do not benefit from acoustic hearing aids, and that simultaneous bilateral implants are used in those who are blind or rely on auditory stimuli as their primary sensory mechanism. Sequential bilateral implants are not recommended, and upgrading a unilateral implant to a bilateral implant is only indicated if a benefit can be proven.

The NHS buys cochlear implants from several companies on long-term contracts, via the national procurement contract. The manufacturers offer discounts on larger orders (e.g. 10 units or more), but often only give discounts for bilateral implants if they are being implanted simultaneously.

A literature review was carried out by NICE on the efficacy of cochlear implants. Thirty-three studies were found, but they were too heterogeneous to carry out a meta-analysis. Only two implant systems (produced by the same manufacturer) noted in the literature were actually available on the NHS contract. The review revealed significant benefits for children fitted with either unilateral or bilateral implants, but the benefit of bilateral implants in adults was less clear, with some studies even suggesting a worsening of symptoms (e.g. tinnitus). The committee was unable to give guidance on whether a second device should be implanted into a patient who already has a unilateral cochlear implant.

A more recent systematic review showed that even elderly patients gain an improved quality of life after a cochlear implant.Reference Berrettini, Baggiani, Bruschini, Cassandro, Cuda and Filipo⁶³

Bilateral implants offer better sound localisation compared with unilateral implants, but there is high inter-individual variability in terms of outcome following the second implant. A second implant can still be beneficial even after a substantial time following the first implant,Reference Smulders, Rinia, Rovers, van Zanten and Grolman⁶⁴ but more research is needed into the cost-effectiveness of this strategy.